GS-5806 is an antifection inhibitor explored for its effectiveness against respiratory syncytial virus (RSV), serving as a potential therapeutic agent in viral infection studies.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
